바이오정보모아 (BioJungboMoa) — ADC · Antibody

8428프로그램 40FDA 승인

69오늘 방문

5,832누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대 Insight

MT027 (MT027)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 7상태 RECRUITING

CGTBiologicstaleNational Heart, Lung, and Blood…Phase 2

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

Peripheral T Cell Lymphoma · CD30

#CD30#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 7상태 RECRUITING

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 2

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

Advanced Esophageal Cancer · Malignant Glioma of Brain

#MalignantGliomaofBrain#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 7상태 ACTIVE

CGTBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-CART19.1 (MB-CART19.1)

Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory · Melanoma Stage III

#MelanomaStageIII#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 7상태 ACTIVE

CGTBiologicstaleCabaletta BioPhase 2

CABA-201 (CABA-201)

Relapsing Multiple Sclerosis (RMS); Progressive Multiple Sclerosis (PMS) · Pemphigus Vulgaris

#PemphigusVulgaris#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 6상태 RECRUITING

CGTBiologicstaleTILT Biotherapeutics Ltd.Phase 2

TILT-123 (TILT-123)

Melanoma; Head and Neck Squamous Cell Carcinoma · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 6상태 RECRUITING

CGTBiologicstaleStephan Grupp MD PhDPhase 2

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

B-cell Acute Lymphoblastic Leukemia; B Lineage Lymphoblastic Lymphoma · CD22

#CD22#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 6상태 RECRUITING

ADCBiologicstaleAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3

임상시험 6상태 RECRUITING

ADCBiologicstaleAstraZenecaPhase 2

AZD0901 (AZD0901)

Gastric Cancer; Gastroesophageal Junction Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 RECRUITING

ADCBiologicstaleAbbViePhase 3

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

Ovarian Cancer; Peritoneal Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 100%임상시험 6상태 RECRUITING

CGTBiologicstaleUSWM CT, LLCPhase 1

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#세포유전치료#CAR-T+2

효능 ORR 0%임상시험 6상태 RECRUITING

ADCBiologicstaleImmunoGen, Inc.Phase 1

IMGN901 (IMGN901)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 0.00%임상시험 6상태 ACTIVE

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 6상태 ACTIVE

ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 34%임상시험 6상태 ACTIVE

CGTBiologicstaleNational Institutes of Health C…Phase 2

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

Metastatic HPV-16 Positive Squamous Cell Anal Cancer · Multi-target

#Multi-target#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 6상태 DISCONTINUED

CGTAAVBiologicstaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Multiple System Atrophy · Multiple System Atrophy

#MultipleSystemAtrophy#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 6상태 RECRUITING

ADCBiologicstaleHoffmann-La RochePhase 2

Atirmociclib (Atirmociclib)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 6상태 RECRUITING

ADCBiologicstaleTasly Pharmaceutical Group Co.,…Phase 2

STRO-002 (STRO-002)

Neoplasm Malignant · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 DISCONTINUED

ADCBiologicstaleSenhwa Biosciences, Inc.Phase 1

Pidnarulex (Pidnarulex)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

임상시험 6상태 RECRUITING

AntibodystaleKite, A Gilead CompanyPhase 1

Lenzilumab (Lenzilumab)

Relapsed/Refractory Large B-cell Lymphoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4

효능 ORR 9.9%임상시험 6상태 DISCONTINUED

CGTBiologicstaleiCell Gene TherapeuticsPhase 1

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 6상태 ACTIVE

CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

B Acute Lymphoblastic Leukemia; Recurrent Acute Lymphoblastic Leukemia · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 6상태 RECRUITING

CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR011 (C-CAR011)

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 6상태 ACTIVE

CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

Central Nervous System Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 6상태 RECRUITING

CGTAAVBiologicstaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF (AAV2-GDNF)

Parkinson's Disease · Parkinson's Disease

#ParkinsonsDisease#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 6상태 RECRUITING

38 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 69 / 5,832

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

MT027 (MT027)

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

MB-CART19.1 (MB-CART19.1)

CABA-201 (CABA-201)

TILT-123 (TILT-123)

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

Sonesitatug vedotin (Sonesitatug vedotin)

AZD0901 (AZD0901)

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

IMGN901 (IMGN901)

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Atirmociclib (Atirmociclib)

STRO-002 (STRO-002)

Pidnarulex (Pidnarulex)

Lenzilumab (Lenzilumab)

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

C-CAR011 (C-CAR011)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

AAV2-GDNF (AAV2-GDNF)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

MT027 (MT027)

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

MB-CART19.1 (MB-CART19.1)

CABA-201 (CABA-201)

TILT-123 (TILT-123)

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

Sonesitatug vedotin (Sonesitatug vedotin)

AZD0901 (AZD0901)

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

IMGN901 (IMGN901)

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Atirmociclib (Atirmociclib)

STRO-002 (STRO-002)

Pidnarulex (Pidnarulex)

Lenzilumab (Lenzilumab)

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

C-CAR011 (C-CAR011)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

AAV2-GDNF (AAV2-GDNF)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

MT027 (MT027)

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

MB-CART19.1 (MB-CART19.1)

CABA-201 (CABA-201)

TILT-123 (TILT-123)

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

Sonesitatug vedotin (Sonesitatug vedotin)

AZD0901 (AZD0901)

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

IMGN901 (IMGN901)

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Atirmociclib (Atirmociclib)

STRO-002 (STRO-002)

Pidnarulex (Pidnarulex)